Australia markets closed

Crescita Therapeutics Inc. (CRRTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.62800.0000 (0.00%)
At close: 9:52AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.6280
Open0.6071
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.6280 - 0.6280
52-week range0.3126 - 0.7910
Volume553
Avg. volume5,059
Market cap13.188M
Beta (5Y monthly)2.37
PE ratio (TTM)314.00
EPS (TTM)0.0020
Earnings date11 May 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
    Business Wire

    Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

    Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting results from its 2021 Annual General and Special Meeting of Shareholders held at its corporate headquarters in Laval, Québec. The detailed results of the votes received by proxy are as follows:

  • Crescita Reports First Quarter 2021 Results
    Business Wire

    Crescita Reports First Quarter 2021 Results

    Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the first quarter ended March 31, 2021 ("Q1-F2021"). All amounts presented are in thousands of Canadian dollars ("CAD") unless otherwise noted.

  • Crescita Therapeutics to Present at the 2021 Bloom Burton & Co. Healthcare Investor Conference
    Business Wire

    Crescita Therapeutics to Present at the 2021 Bloom Burton & Co. Healthcare Investor Conference

    Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company, is pleased to announce that its President and CEO, Serge Verreault will be presenting at the upcoming Bloom Burton & Co. Healthcare Investor Conference taking place virtually on April 20 and 21, 2021.